Cardiac amyloidosis: evolving approach to diagnosis and management
HK Meier-Ewert, V Sanchorawala, JL Berk… - … treatment options in …, 2011 - Springer
… Therefore, dual organ heart/liver transplantation should be considered in patients with
familial transthyretin amyloidosis complicated by infiltrative cardiomyopathy [50]. The advent of …
familial transthyretin amyloidosis complicated by infiltrative cardiomyopathy [50]. The advent of …
Cardiac transthyretin amyloidosis
… We review here the clinical features of cardiac ATTR amyloidosis and describe the diagnostic
tests to determine ATTR type. Correct diagnosis is ever more crucial given that several …
tests to determine ATTR type. Correct diagnosis is ever more crucial given that several …
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal
Y Ando, M Waddington-Cruz, Y Sekijima… - Orphanet Journal of …, 2023 - Springer
Hereditary transthyretin (ATTRv) amyloidosis is a rare and autosomal dominant disorder
associated with mutations in the transthyretin gene. Patients present with diverse symptoms …
associated with mutations in the transthyretin gene. Patients present with diverse symptoms …
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis
L Obici, OB Suhr - Clinical Autonomic Research, 2019 - Springer
… To review the management of gastrointestinal symptoms in patients with hereditary transthyretin
amyloidosis, discussing diagnostic evaluations, assessment of disease progression and …
amyloidosis, discussing diagnostic evaluations, assessment of disease progression and …
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts
C Karam, ML Mauermann, A Gonzalez‐Duarte… - Muscle & …, 2024 - Wiley Online Library
… A key part of disease management for patients diagnosed with ATTRv amyloidosis includes
symptomatic treatments, which can reduce symptom burden but do not affect the underlying …
symptomatic treatments, which can reduce symptom burden but do not affect the underlying …
[HTML][HTML] Cardiac amyloidosis: epidemiology, diagnosis and therapy
G Papingiotis, L Basmpana, D Farmakis - EJ Cardiol Pract, 2021 - escardio.org
… Among the different types of amyloidosis, nearly all cases of clinical cardiac amyloidosis (>95%)
are caused by light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) [3,4]. …
are caused by light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) [3,4]. …
Systemic amyloidosis from A (AA) to T (ATTR): a review
E Muchtar, A Dispenzieri, H Magen… - Journal of internal …, 2021 - Wiley Online Library
… resulting in diagnostic delay. The field of amyloidosis has seen significant improvements
over the past decade in diagnostic accuracy, prognosis prediction and management. The …
over the past decade in diagnostic accuracy, prognosis prediction and management. The …
Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options
H Alkhawam, D Patel, J Nguyen, SM Easaw… - Acta …, 2017 - Taylor & Francis
… There are not many differences in the therapy of heart failure due to light-chain amyloid (AL)
and that of transthyretin amyloidosis (TTR). Diuretics form the mainstay of treatment in …
and that of transthyretin amyloidosis (TTR). Diuretics form the mainstay of treatment in …
Inotersen treatment for patients with hereditary transthyretin amyloidosis
MD Benson, M Waddington-Cruz, JL Berk… - … England Journal of …, 2018 - Mass Medical Soc
… diagnosis of stage 1 (patient is ambulatory) or stage 2 (patient is ambulatory with assistance)
hereditary transthyretin amyloidosis … besides hereditary transthyretin amyloidosis, previous …
hereditary transthyretin amyloidosis … besides hereditary transthyretin amyloidosis, previous …
Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment
OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018 - Elsevier
… to describe clinical features, diagnostic tools, and … a diagnostic algorithm for identification
of cardiac amyloidosis. While treatment has historically focused on symptomatic management …
of cardiac amyloidosis. While treatment has historically focused on symptomatic management …